Aloe vera and Potassium drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Aloe vera (aloe) and Potassium (potassium). Common drug interactions include nasopharyngitis among females and somnolence among males.
The phase IV clinical study analyzes what interactions people have when they take Aloe vera and Potassium. It is created by eHealthMe based on reports of 86 people who take the same drugs from the FDA, and is updated regularly.
What is Aloe vera?
Aloe vera has active ingredients of aloe. eHealthMe is studying from 1,457 Aloe vera users. Check the latest studies of Aloe vera.
What is Potassium?
Potassium has active ingredients of potassium. It is often used in hypokalemia. eHealthMe is studying from 59,147 Potassium users. Check the latest studies of Potassium.
86 people who take Aloe vera and Potassium together, and have interactions are studied.

What are the common drug interactions of Aloe Vera and Potassium, by gender? *:
female:
- Nasopharyngitis (inflammation of the nasopharynx)
- Nausea (feeling of having an urge to vomit)
- Nephrolithiasis (calculi in the kidneys)
- Oral pain
- Portal hypertensive gastropathy (changes in the mucosa of the stomach in patients with portal hypertension;)
- Stomatitis (inflammation of mucous membrane of mouth)
- Abdominal discomfort
- Abdominal pain
- Adverse event
- Alopecia (absence of hair from areas of the body)
male:
- Somnolence (a state of near-sleep, a strong desire for sleep)
- Blood uric acid increased
- Stress
- Abdominal pain
- Dry mouth
- Hypophosphataemia (electrolyte disturbance in which there is an abnormally low level of phosphate in the blood)
- Nausea (feeling of having an urge to vomit)
- Ventricular fibrillation (abnormally irregular heart rhythm)
- Appendicitis (inflammation of the appendix)
- Ascites (accumulation of fluid in the abdominal cavity)
What are the common drug interactions of Aloe Vera and Potassium, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
- Bronchial disorder
- Injection site erythema (redness at injection site)
- Knee arthroplasty
- Lower respiratory tract infection
- Nasopharyngitis (inflammation of the nasopharynx)
- Pneumonia
- Pulmonary fibrosis (formation or development of excess fibrous connective tissue (fibrosis) in the lungs)
- Pulmonary mass
- Pyrexia (fever)
- Sputum discoloured
30-39:
- Pharyngitis (inflammation of the pharynx, causing a sore throat)
40-49:
- Asthma
- Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
- Dyspnoea (difficult or laboured respiration)
- Fatigue (feeling of tiredness)
- Fungal infection
- Headache (pain in head)
- Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development)
- Injection site erythema (redness at injection site)
- Injection site pruritus (severe itching at injection site)
- Injection site rash
50-59:
- Nasopharyngitis (inflammation of the nasopharynx)
- Rash pruritic (redness with itching)
- Scar
- Skin exfoliation (removal of the oldest dead skin cells)
- Skin lesion
- Stupor (lack of critical cognitive function and level of consciousness)
- Suicidal ideation
- Urticaria (rash of round, red welts on the skin that itch intensely)
- Rash
- Abdominal pain
60+:
- Somnolence (a state of near-sleep, a strong desire for sleep)
- Abdominal distension
- Dyspnoea (difficult or laboured respiration)
- Myasthenia gravis (a chronic condition that causes muscles to tire and weaken easily)
- Stress
- Abdominal pain
- Drug hypersensitivity
- Ventricular fibrillation (abnormally irregular heart rhythm)
- Appendicitis (inflammation of the appendix)
- Ascites (accumulation of fluid in the abdominal cavity)
What are the existing conditions these people have? *
- Diabetes: 32 people, 37.21%
- Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 31 people, 36.05%
- Constipation: 31 people, 36.05%
- Neuralgia (pain in one or more nerves): 31 people, 36.05%
- High Blood Cholesterol: 31 people, 36.05%
- Stress And Anxiety: 30 people, 34.88%
- Dyspnea (difficult or laboured breathing): 30 people, 34.88%
- Ventricular Fibrillation (abnormally irregular heart rhythm): 29 people, 33.72%
- Thrombosis (formation of a blood clot inside a blood vessel): 29 people, 33.72%
- Bacterial Infection: 29 people, 33.72%
* Approximation only. Some reports may have incomplete information.
Do you take Aloe vera and Potassium?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
Browse all drug interactions of Aloe vera and Potassium:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Aloe vera:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Potassium:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Aloe vera and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Potassium and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on aloe and potassium (the active ingredients of Aloe vera and Potassium, respectively), and Aloe vera and Potassium (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Drug interactions of Profen and Impoyz - 4 seconds ago
- Drug interactions of Vesicare and Hydrocodone Bitartrate And Acetaminophen - 7 seconds ago
- Turmeric and Vitamin D3 drug interactions for women aged 50-59 - 7 seconds ago
- Remodulin and Gastric Ulcer for Women aged 50-59 - 9 seconds ago
- Remodulin and Peptic Ulcer for Women aged 50-59 - 9 seconds ago
- Remodulin and Ulcer - Peptic for Women aged 50-59 - 9 seconds ago
- Remodulin and Ulcer - Duodenal Or Gastric for Women aged 50-59 - 9 seconds ago
- Remodulin and Duodenal Ulcer for Women aged 50-59 - 10 seconds ago
- Remodulin and Uric Acid for Women aged 50-59 - 10 seconds ago
- Remodulin and Ulcer for Women aged 50-59 - 10 seconds ago